MATWIN offers an outreach session in Paris on September 8th and 9th 2016 to every cancer innovation project leader (including off MATWIN programme).
« Optimise cancer innovation maturation (therapy, diagnostic or medical device)
: from research to early clinical stage».
The stated goal is to allow participants to identify cancer innovation development (therapy, diagnostic or medical device) main challenges, constraints and key success factors, from research to early clinical stage through various thematic areas (strategic framework, business plan, key success factors from preclinical development to early clinical stage, regulatory framework, patent strategy, maturation funding, etc…)
Have a view on the program.
This year, MATWIN associates with Cancer Campus biocluster (http://www.cancer-campus.com/fr/qui-sommes-nous) to offer an even more diversified program including regulatory issues associated with diagnostic and medical device but also funding issues.
